News Release

November 8, 2021

Notice of Establishment of Medical Device Sales Subsidiary in the Socialist Republic of Vietnam (200KB)

November 5, 2021

Joint Establishment of a CTA Dialyzer Production Plant with Toyobo —Strengthen the production system to meet growing global demand— (179KB)

November 4, 2021

Notice of Establishment of Overseas Offices in China (153KB)

September 9, 2021

Publishment of NIPRO CORPORATION Social Finance Framework (496KB)
Issuance of Second Opinion by R&I (693KB)

September 6, 2021

Notice of Establishment of Overseas Offices in China (294KB)

August 18, 2021

Notice of Results of Human Coronavirus (OC43) Inactivation Performance Test by Humidification Using Ionless™ Hypochlorous Acid Water CL Fine^® (818KB)

May 26, 2021

Notice of Contract Manufacturing Agreement for Domestic Supply of AstraZeneca COVID-19 vaccine “Vaxzevria™ intramuscular injection” (160KB)

May 17, 2021

Acquisition of Shares of a Pharmaceutical Glass Container Manufacturing and Sales Company by a Nipro Overseas Subsidiary (354KB)

April 26, 2021

Acquisition of Shares of Changsha Bairong Dialysis Center and Shenyang Yizhiyuan Dialysis Center in China (192KB)

April 6, 2021

Notice of Establishment of an Overseas Office in China (301KB)

January 5, 2021

New Year's Message from President Sano of Nipro Corporation Delivered January 5, 2021 (257KB)